Interferon Therapy [topp]    
HEPATOCELLULAR CARCINOMA [neop]    
national [popg]    
Surveillance Program [resa]    
Cirrhotic [qlco]    
Non-cirrhotic [qlco]    
Patients [podg]    
Chronic hepatitis C [dsyn]    
JAPAN [geoa]    
Previous [tmco]    
Interferon Therapy [topp]    
HEPATOCELLULAR CARCINOMA [neop]    
Assessed [acty]    
Degree [qlco]    
Fibrosis, Liver [dsyn]    
Risk Factor [qnco]    
HEPATOCELLULAR CARCINOMA [neop]    
Objective [inpr]    
Evaluate [hlca]    
Interferon Therapy [topp]    
HEPATOCELLULAR CARCINOMA [neop]    
Risk Factors [qnco]    
Including [ftcn]    
Degree [qlco]    
Fibrosis, Liver [dsyn]    
Design [acty]    
Retrospective Cohort Study [resa]    
Setting [ftcn]    
Seven [qnco]    
REGIONAL [spco]    
Core [spco]    
JAPAN [geoa]    
Patients [podg]    
Patients [podg]    
Chronic hepatitis C [dsyn]    
Liver Biopsy [diap]    
Patients [podg]    
RECEIVED [qlco]    
untreated [fndg]    
measurements [ftcn]    
Degree [qlco]    
Fibrosis, Liver [dsyn]    
Assessed [acty]    
Stage [tmco]    
FIBROSIS [patf]    
Stage [tmco]    
CIRRHOSIS [dsyn]    
Response [orga]    
Screening [hlca]    
HEPATOCELLULAR CARCINOMA [neop]    
Performed [ftcn]    
Periodically [tmco]    
Average [qnco]    
YEARS [tmco]    
Interferon Therapy [topp]    
HEPATOCELLULAR CARCINOMA [neop]    
Proportional [qlco]    
Hazards [qlco]    
Regression [patf]    
HEPATOCELLULAR CARCINOMA [neop]    
Treated [ftcn]    
Patients [podg]    
untreated [fndg]    
Patients [podg]    
untreated [fndg]    
Patients [podg]    
Annual [tmco]    
HEPATOCELLULAR CARCINOMA [neop]    
Increased [qnco]    
Degree [qlco]    
Fibrosis, Liver [dsyn]    
Patients [podg]    
Stage [tmco]    
FIBROSIS [patf]    
7 - 9 [fndg]    
Patients [podg]    
Stage [tmco]    
FIBROSIS [patf]    
Cumulative [qlco]    
In [qnco]    
Treated [ftcn]    
untreated [fndg]    
Patients [podg]    
Patients [podg]    
Stage [tmco]    
F2 [qnco]    
FIBROSIS [patf]    
Stage [tmco]    
FIBROSIS [patf]    
Interferon Therapy [topp]    
Reduced [qlco]    
HEPATOCELLULAR CARCINOMA [neop]    
Adjusted [ftcn]    
Risk Ratio [qnco]    
CI [geoa]    
Patients [podg]    
SUSTAINED VIROLOGIC RESPONSE [fndg]    
Risk Ratio [qnco]    
CI [geoa]    
persistently [idcn]    
NORMAL [qlco]    
Serum alanine levels [lbpr]    
Risk Ratio [qnco]    
CI [geoa]    
Alanine Aminotransferase level [lbtr]    
Two Times [qnco]    
UPPER [spco]    
limit [ftcn]    
NORMAL [qlco]    
Risk Ratio [qnco]    
CI [geoa]    
Conclusions [idcn]    
Interferon Therapy [topp]    
HEPATOCELLULAR CARCINOMA [neop]    
Virologic [ftcn]    
Biochemical [ftcn]    
